A Multicenter Open Label Study of QRX003 Topical Lotion in Netherton Syndrome Patients Who Are Currently Receiving Systemic Biologic Therapy. ASHBURN, Va., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, announces that it… Read More..

-Company Expects Stronger Q4 and FY 2023 ending February 2023- -Conference Call Tuesday, October 18, 2022 at 10:00 am ET- MILTON, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) --  via NewMediaWire -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its second… Read More..

Presentation on Tuesday, October 25th at 8:00 AM PT SAN FRANCISCO, CA, Oct. 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment, facilities, and services, today announced… Read More..